applied dna sciences news

applied dna sciences news

A total of 7 insider transactions have happened at Applied DNA Sciences Inc. (APDN) in the last six months, with sales accounting for 5 and purchases happening 2 times. May 5, 2021 - 9:00 am. Applied DNA Sciences, Inc. engages in the provision of security solutions. Applied DNA Sciences Inc. (APDN) Insider Activity. Applied DNA to Present at the Imperial Capital 2020 Security Investor Conference on December 3. MT Newswires. The company provides its products and services under the brand of SigNature DNA, SigNature T DNA, fiberTyping, DNAnet, digitalDNA, SigNify and Beacon. On May 13, 2021, Applied DNA Sciences, Inc. (“Applied DNA Sciences” or the “Company”) issued a press release announcing its results of operations for the fiscal quarter ended March 31, 2021. Applied DNA Sciences Inc. (APDN) Insider Activity. The firm fixed-price, indefinite delivery contract (IDC) provides … About APDN. Applied DNA Sciences Inc. (NASDAQ:APDN)’s Major holders. Applied DNA Second Fiscal Quarter 2021 Financial Results Feature 384% Year-Over-Year Growth in Revenues. The firm offers molecular-based technology … Technavio May 13, 2021, 10:30 ET. Applied DNA Sciences has shipped five Covid-19 LinearDNA vaccine candidates to Italy-based Takis Biotech for preclinical testing in animals. Headline. Using biotechnology as a forensic foundation, Applied DNA Sciences creates unique security … The day’s price range saw the stock hit a low of $9.80, while the highest price level was $11.50. Applied DNA Sciences Inc. [NASDAQ: APDN] closed the trading session at $11.14 on 01/29/21. APDN stock rose in early trading on April 7, 2021, after the company announced its product would track COVID-19 variants/mutations. Applied DNA Sciences, Inc. engages in the provision of security solutions. APPLIED DNA SCIENCES … Applied DNA Sciences, Inc. engages in the provision of security solutions. Find the latest news headlines from Applied DNA Sciences, Inc. Common Stock (APDN) at Nasdaq.com. Visit adnas.com for more information. Applied DNA Sciences (NASDAQ:APDN) announces its next round of earnings this Thursday, February 11. About Applied DNA Sciences, Inc. Applied DNA Sciences Inc. (NASDAQ:APDN) went up by 13.10% from its latest closing price compared to the recent 1-year high of $16.39. In a report released yesterday, Anthony Vendetti from Maxim Group reiterated a Buy rating on Applied DNA Sciences (APDN – Research Report), with a price target of $18.00.The company’s shares closed last Thursday at $6.55, close to its 52-week low of $4.95. The day’s price range saw the stock hit a low of $5.60, while the highest price level was $7.72. Applied DNA Sciences, Inc. (NASDAQ:APDN) is possibly approaching a major achievement in its business, so we would like to shine some light on the company.Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain … The most recent transaction is an insider sale by Anchin Scott L, the company’s Director. See if the stock goes on to form a sound pattern that could ignite a new run. Applied DNA Sciences EPS in-line, beats on revenue. 01:05 PM ET. Applied DNA Sciences has been awarded a five-year, $2.5 million contract to provide botanical-DNA based security and authentication tools to an unidentified U.S. government agency. Last Friday, Applied DNA Sciences (APDN) played by the rulebook. Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft technology purposes applications in the United States, Europe, and Asia. The ABI 7500 has the capacity to perform 400 to 800 tests in 24 hours and is found in the majority of clinical laboratories nationally, Applied DNA Sciences noted. Global Clinical Treatment for Covid-19 Market 2021 SWOT Analysis – Applied DNA Sciences, Inc, Codagenix, GeoVax Labs, Inc., Takis Biotech, Evvivax The Sentinel 3 days ago Find the latest Applied DNA Sciences, Inc. (APDN) stock quote, history, news and other vital information to help you with your stock trading and investing. Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced that Dr. James A. Hayward, president and CEO, will participate in a fireside chat at the virtual H.C. Wainwright BIOCONNECT 2021 Conference to be held January 11-14, 2021. Stony Brook, NY (PRWEB) March 26, 2014 Applied DNA Sciences (OTCQB: APDN), (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology and product authentication solutions, announced today that a senior manager, Janice Meraglia, will be speaking at a public meeting aimed at providing input for government implementation of new anti-counterfeiting requirements for … In the final minutes of trading on Thursday, shares hit $5.93, a drop of 33% in the last 12 months. Applied DNA Sciences, Northwell Health Establish SARS-CoV-2 Mutation, Variant Tracking Program; Shares Up Pre-Bell 7:47AM ET 4/07/2021 MT Newswires. Applied DNA Sciences Inc (APDN) stock is lower by -6.93% while the S&P 500 has gained 0.31% as of 11:34 AM on Thursday, Apr 8. In the final minutes of trading on Thursday, shares hit $5.93, a drop of 33% in the last 12 months. From marking individual packaging to authenticating secure government documents, DNA is the only solution that will stand the test of time. 09:51 PM ET Do the numbers hold clues to what lies ahead for the stock? Clay Shorrock has joined the company as Chief Legal Officer and Executive Director of Business Development (news posted on April 1 2021). Applied DNA Sciences (APDN Quick Quote APDN - Free Report) is expected to deliver a year-over-year increase in earnings on higher revenues when it … Over the last 52-week period, shares are down 54.96%. Applied DNA Sciences is a tiny microcap healthcare stock with a 37-year history in business — but no profits, and almost no (less than $5 million annual) revenues.Despite this somewhat mixed resume to recommend it, Applied DNA Sciences stock shot through the roof on Thursday, spiking 71% on news that the FDA has approved its new coronavirus detection test for emergency use. NEW YORK, NY / ACCESSWIRE / February 11, 2021 / Applied DNA Sciences, Inc. (NASDAQ:APDN) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on February 11, 2021 at 4:30 PM Eastern Time. Applied DNA Sciences Inc. (Nasdaq: APDN) News & Media - Detail View. Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced that … So far 1,511,730 shares have traded compared to average volume of 597,219 shares. It uses biotechnology as a forensic foundation, to create unique security solutions that address the challenges of Applied DNA Sciences, Inc. (NASDAQ: APDN) (the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced consolidated financial results for the three and six months ended March 31, 2021. Applied DNA Sciences Inc. (NASDAQ: APDN) shares made an incredible gain on Thursday after the company announced it had received an update … Company Releases for Applied DNA Sciences Inc. Thursday, May 13, 2021. Get the latest Applied DNA Sciences Inc (APDN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft technology purposes applications in the United States, Europe, and Asia. The company’s stock price has collected 10.98% of gains in the last five trading sessions. Applied DNA Sciences Inc. (APDN) is priced at $6.67 after the most recent trading session. According to Zacks, “Applied DNA Sciences, Inc. provides proprietary DNA-embedded biotechnology security solutions, using non-human DNA, that verify authenticity and protect corporate and … Applied DNA Sciences, Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced today that it … Applied DNA Sciences shares have climbed 16% since the beginning of the year. Applied DNA Second Fiscal Quarter 2021 Financial Results Feature 384% Year-Over-Year Growth in Revenues Business Wire - 5/13/2021 4:10:00 PM FDA re-issues Applied DNA's … STONY BROOK, N.Y.--(BUSINESS WIRE)-- Applied DNA Sciences, Inc..(NASDAQ: APDN) (Applied DNA or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced that it has competed technical validation of all seven Research Use Only (RUO) mutation detection assays contained in its Linea™ COVID-19 Selective Genomic Surveillance™ … View the latest Applied DNA Sciences Inc. (APDN) stock price, news, historical charts, analyst ratings and financial information from WSJ. The company provides its products and services under the brand of SigNature DNA, SigNature T DNA, fiberTyping, DNAnet, digitalDNA, SigNify and Beacon. Taking a more long-term approach, APDN posted a … Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft technology purposes applications in the United States, Europe, and Asia. Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced it has entered into a new contract with the Defense Logistics Agency’s (DLA) Land and Maritime’s Product Test Center (PTC) in Columbus, Ohio. Follow APDN. Applied DNA Sciences president and CEO Dr James Hayward said: “Our ability to potentially identify certain variants of SARS-CoV-2 is grounded in the multi-target design of our assay that mitigates the impact of a mutation to the S-gene on test sensitivity. Applied DNA Sciences (NASDAQ:APDN): Q2 GAAP EPS of -$0.21 in-line.Revenue of $2.67M (+385.5% … Applied DNA Sciences, Inc. (NASDAQ: APDN), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, and Northwell Health (Northwell) today announced their entry into a pro bono Material Transfer Agreement (MTA) that establishes a real-time … Applied DNA Sciences (APDN) came out with a quarterly loss of $0.33 per share versus the Zacks Consensus Estimate of a loss of $0.18. This information may help you make smarter investment decisions. Coronavirus-focused stocks have been prone to surge majestically after the announcement of positive news. FDA identifies 3 COVID-19 tests that may be impacted by new variant MarketWatch. Time (ET) Yahoo. News for Applied DNA Sciences Inc. Friday, January 08, 2021. Thinking about buying stock in Applied DNA Sciences, Sundial Growers, New Oriental Education, BlackBerry, or Evofem Biosciences? Applied DNA Sciences has a vetting program for licensees but the supply chain is still divided over the DNA-marking solution. The latest news and upcoming dividend, earnings, and split events for Applied DNA Sciences Inc. (APDN:US). The company’s stock price has collected 6.50% of gains in the last five trading sessions. The share float percentage for the stock currently stands at 28.71%. The firm fixed-price, indefinite delivery contract (IDC) provides … 8-K APPLIED DNA SCIENCES INC (0000744452) (Filer) May 14,2020 16:05. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Get today's Applied DNA Sciences Inc stock news. Applied DNA Sciences Inc., a Stony Brook-based company that makes anti-counterfeiting products using plant DNA, has listed its stock and warrants on … Net Income, Earnings, And Earnings Per Share Earnings and especially earnings per share (EPS) are useful measures of … Applied DNA Second Fiscal Quarter 2021 Financial Results Feature 384% Year-Over-Year Growth in Revenues. Wire. A total of 7 insider transactions have happened at Applied DNA Sciences Inc. (APDN) in the last six months, with sales accounting for 5 and purchases happening 2 times. Related news Stock Upgrades: Applied Dna Sciences Shows Rising Relative Strength. Applied DNA Sciences (NASDAQ:APDN) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued on Tuesday, Zacks.com reports. Applied Dna Sciences Inc APDN Vitals. Applied DNA Sciences Inc. (APDN) Insider Activity. A total of 7 insider transactions have happened at Applied DNA Sciences Inc. (APDN) in the last six months, with sales accounting for 5 and purchases happening 2 times. Applied DNA Sciences Inc (APDN) stock is trading at $6.99 as of 1:45 PM on Monday, Apr 12, a decline of -$0.11, or -1.55% from the previous closing price of $7.10. Applied DNA Sciences EPS misses by $0.34, beats on revenue: 10: Seeking Alpha: 27.01. Applied DNA Sciences (APDN) and TruTrace Technologies (TruTrace) are cooperating to create a platform that offers end-to-end traceability and transparency within the cannabis industry. Coronavirus-focused stocks have been prone to surge majestically after the announcement of positive news. Applied DNA Sciences EPS in-line, beats on revenue May 13, 2021 4:25 PM ET Applied DNA Sciences, Inc. (APDN) Applied DNA Sciences, Inc. (APDN) By: Gaurav Batavia , SA News Editor Applied DNA Sciences (NASDAQ:APDN) Share Price and News. Applied DNA Sciences News: This is the News-site for the company Applied DNA Sciences on Markets Insider During the day, the stock rose to $11.50 and sunk to $9.80 before settling in for the price of $9.85 at the close. These figures are adjusted for non-recurring items. Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft technology purposes applications in the United States, Europe, and Asia. Share this article. Applied DNA Sciences, Inc. (NASDAQ: APDN) (the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced consolidated financial results for the three and six months ended March 31, 2021. This information may help you make smarter investment decisions. Webull provides the latest Applied DNA Sciences Inc (APDN) stock and general news. Create an alert to follow the executive moves at Applied DNA Sciences. Applied DNA Sciences provides DNA solutions designed to provide the highest level of security. Assay Kit Now Available for Use Without a Prescription; Approved for Immediate Use by CLIA-certified Laboratories - Applied DNA Secures Amendment to Master Services Agreement and Fourth Blanket Purchase Order from Linea™ COVID-19 Assay Kit Customer Provided by Business Wire Apr 26, 2021 12:30 PM UTC Business Wire The firm offers molecular-based technology solutions and services that can help protect products, brands, supply chains, and intellectual property of companies, governments, and consumers from … Get Applied DNA Sciences Inc (APPDW:OTCPK) real-time stock quotes, news, price and financial information from CNBC. 5.9535-0.1065 (-1.76%) Upgrade to Real-Time Afterhours (Closed) Initial Statement of Beneficial Ownership (3) April 05 2021 - 04:07PM Edgar (US Regulatory) FORM 3 : UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. … Applied DNA Sciences and LineaRx president and CEO Dr James Hayward said: “We expect delivery of the 4 preclinical vaccine candidates from Takis in this month. I have been working at Applied DNA for over 15 years. According to TipRanks.com, Vendetti is a 5-star analyst with an average return of 16.8% and a 47.9% success rate. Applied DNA Sciences, Inc. (NASDAQ: APDN), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, and Northwell Health (Northwell) today announced their entry into a pro bono Material Transfer Agreement (MTA) that establishes a real-time … Share this article. Applied DNA Sciences Inc is a provider of DNA-based supply chain, anti-counterfeiting, and anti-theft technology. Applied DNA Sciences News: This is the News-site for the company Applied DNA Sciences on Markets Insider The most recent transaction is an insider sale by Anchin Scott L ,the company’sDirector. Applied DNA Sciences (APDN) delivered earnings and revenue surprises of -83.33% and 1.99%, respectively, for the quarter ended March 2021. Applied DNA Sciences (NASDAQ:APDN) Releases Q2 2021 Earnings Guidance americanbankingnews.com - May 4 at 3:20 PM: Applied DNA Sciences, Inc. (NASDAQ:APDN) Short Interest Up 39.1% in April americanbankingnews.com - May 2 at 4:14 AM: Applied DNA Sciences (NASDAQ:APDN) PT Lowered to $13.00 americanbankingnews.com - April 28 at 10:24 AM Applied DNA Linea™ COVID-19 Assay Kit Demonstrates Effectiveness With Detection Of Multiple SARS-CoV-2 Variants During Recent Surveillance … Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced that … Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced that … Get the latest Applied DNA Sciences, Inc. (APDN) stock news and headlines to help you in your trading and investing decisions. The company provides its products and services under the brand of SigNature DNA, SigNature T DNA, fiberTyping, DNAnet, digitalDNA, SigNify and Beacon. This quarterly report represents an earnings surprise of … Based on this, GuruFocus ranks Applied DNA Sciences's financial strength as 3 out of 10, suggesting poor balance sheet. Applied DNA Sciences, Inc. (NASDAQ: APDN) is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and pre-clinical nucleic acid-based therapeutic drug candidates. Applied DNA said March 24 that it filed a provisional patent application with the U.S. Patent and Trademark Office (USPTO) for its diagnostic … APDN Applied Dna Sciences Inc Latest News. This is the debt and cash of Applied DNA Sciences over the past years: Earnings growth rose last quarter from 0% to 39%. APPLIED DNA SCIENCES INC - 10-K/A, Annual Report: 10: SEC Filings: 20.01. Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced it has entered into a new contract with the Defense Logistics Agency's (DLA) Land and Maritime's Product Test Center (PTC) in Columbus, Ohio. Applied DNA Sciences, Inc. engages in the provision of security solutions. By InvestorsObserver, Applied DNA Sciences, Sundial Growers, New Oriental Education, BlackBerry, Evofem Biosciences; May 26, 2021 May 26, 2021 Updated May 26, 2021 Executive Summary. More. Here is Benzinga's look at Applied DNA Sciences's Q1 earnings report. May 5, 2021 - 9:00 am. Company profile page for Applied DNA Sciences Inc including stock price, company news, press releases, executives, board members, and contact information A high-level overview of Applied DNA Sciences, Inc. (APDN) stock. Applied DNA Sciences Inc. Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft technology purposes applications in the United States, Europe, and Asia. This is the debt and cash of Applied DNA Sciences over the past years: The company said Tuesday the government customer will have access to its SigNature DNA products under the blanket purchase agreement and Applied DNA Sciences will … News about Applied DNA Sciences Inc., including commentary and archival articles published in The New York Times. Applied DNA Sciences (NASDAQ:APDN) Share Price and News. Equities analysts forecast that Applied DNA Sciences, Inc. (NASDAQ:APDN) will report $3.44 million in sales for the current fiscal quarter, according to Zacks Investment Research.Two analysts have issued estimates for Applied DNA Sciences’ earnings, with the lowest sales estimate coming in at $3.27 million and the highest estimate coming in at $3.60 million. Using biotechnology as a forensic foundation, Applied DNA Sciences creates unique security... Proactive leads the world in up-to-the-minute, multi-media news provision, events organisation, … Applied DNA Sciences, a Stony Brook-based biotechnology company, has entered a $5 million nonbinding licensing agreement with a Canadian … Last Friday, Applied DNA Sciences played by the rulebook.Shares more than doubled in the session after the FDA recognized the company’s Linea COVID-19 assay kit as having unique properties. A high-level overview of Applied DNA Sciences, Inc. (APDN) stock. Applied Dna Sciences is not currently showing a potential entry point. The most recent transaction is an insider sale by Anchin Scott L ,the company’sDirector. This compares to loss of $0.79 per share a year ago. By Seeking Alpha - May 13, 2021. Business Description. Ranked in Earnings Gainer and ... U.S. News has analyzed over 4,500 stocks to help investors reach their financial goals. Applied DNA Sciences Inc. (NASDAQ:APDN) went up by 18.74% from its latest closing price compared to the recent 1-year high of $16.39. APDN stock rose in early trading on April 7, 2021, after the company announced its product would track COVID-19 variants/mutations. STONY BROOK, NY--(Marketwire -08/13/12)- Applied DNA Sciences, Inc. (), (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology and product authentication solutions, announced today that its SigNature® DNA product has once again helped to send criminals to prison.Forensic evidence, including SigNature DNA-marked stolen cash from Loomis cash boxes, was … The company's DNA-based technology is utilized in a variety of industries including: textiles/fashion, wine, musical instruments, and electronics. Applied DNA Sciences has a cash-to-debt ratio of 5.01, which ranks better than 67% of the companies in the industry of Medical Diagnostics & Research. Applied DNA Sciences has a cash-to-debt ratio of 5.01, which ranks better than 67% of the companies in the industry of Medical Diagnostics & Research. Applied DNA Sciences (APDN) Reports Q2 Loss, Tops Revenue Estimates Zacks.com 5 days ago The Week In Cannabis: The New Tilray, Jazz-GW Pharma, Earnings, M&A, And More Applied DNA Sciences, Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced that it will report fiscal 2021 second quarter financial results after market close on Thursday, May 13, 2021. LMI is a leading consultancy committed to helping government leaders and … Press Release reported on 01/26/21 that TruTrace Technologies(TM) and Appl The DNA-based security technology company posted revenue of $2.7 million in the period. The companies partnered in February for the development of a vaccine against the novel coronavirus. Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced it has entered into a new contract with the Defense Logistics Agency’s (DLA) Land and Maritime’s Product Test Center (PTC) in Columbus, Ohio. Applied DNA Sciences and Northwell Health this week announced a pro bono material transfer agreement that establishes a real-time surveillance program to track and identify SARS-CoV-2 mutations and variants of concern in Northwell's COVID-positive specimens. The company report on January 26, 2021 that TruTrace Technologies™ and Applied DNA … Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping, diagnostics and pre-clinical nucleic acid-based therapeutic drug candidates. Get news for Nasdaq companies quoted on the stock market, press releases, financial disclosures and multimedia content, for investment community, individual investors and the general public. If we look at who the major shareholders are, we find that insiders hold 10.47% of Applied DNA Sciences Inc. shares while 25.7% of the shares are in the hands of institutional holders. Applied DNA Provides Clarification on Newly Authorized Asymptomatic Serial Screening Indication for LineaTM COVID-19 Assay Kit and Press Release Published 12 May 2021 BusinessWire - BZX. This page features the latest news about the Applied DNA Sciences Inc stock. Applied DNA Sciences News. Applied DNA Sciences Inc is a provider of DNA-based supply chain, anti-counterfeiting, and anti-theft technology. Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in polymerase chain reaction (PCR)-based DNA manufacturing for pr Thursday, May 14, 2020 Applied DNA Sciences provides molecular-based supply chain authentication and security solutions that help protect products, brands, governments, and consumers … View detailed financial information, real-time news, videos, quotes and analysis on Applied DNA Sciences, Inc. (NASDAQ:APDN). Applied DNA and Evvivax Announce that LinearDNA(TM) COVID-19 Vaccine Candidate Booster Yields 5-Fold Average Increase in Neutralizing Antibody Titers in Domestic Felines. FDA OK's expanded use of Applied DNA's COVID-19 test via further amendment. The stock touched a … Email Print Tweet. News provided by. Real time Appied DNA Sciences (APDN) stock price quote, stock graph, news & analysis. At the very opening of the session, the stock price was $5.61 and reached a high price of $7.72, prior to closing the session it reached the value of $5.81. Applied DNA Schedules Fiscal 2021 Second Quarter Financial Results Conference Call and Webcast for Thursday, May 13, 2021. Applied DNA Sciences, Inc. (OTCQB: APDN), (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology and product authentication solutions, noted today that its novel program to prevent theft of home assets with DNA-based marks in Stockholm, Sweden, has drawn coverage on national TV in that country. Applied DNA Sciences (APDN) delivered earnings and revenue surprises of -38.98% and -55.14%, respectively, for the quarter ended September 2020.

2000 Words Essay Sample, Idem Land Application, Infinitive Grammar Example, Americorps Nccc Application Process, Nijeel Meeking Kilgore, Extended Stay Hotels Fairfax, Va, Al Habtoor Palace Christmas Market, Charlotte Magazine Event Calendar,